Eduardo Franco - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Obstetrics and Gynecology, Genetics, Microbiology Biology

381 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Logel M, El-Zein M, Franco EL, Gonzalez E. Species-level characterization of the cervicovaginal microbiota and its role in human papillomavirus-associated cervical carcinogenesis. Journal of Medical Virology. 96: e29764. PMID 38923577 DOI: 10.1002/jmv.29764  0.421
2024 Gottschlich A, Hong Q, Gondara L, Alam MS, Cook DA, Martin RE, Lee M, Melinikow J, Peacock S, Proctor L, Stuart G, Franco EL, Krajden M, Smith LW, Ogilvie GS. Evidence of decreased long-term risk of cervical pre-cancer after negative primary HPV screens compared to negative cytology screens in a longitudinal cohort study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 38773687 DOI: 10.1158/1055-9965.EPI-23-1587  0.415
2024 Malagón T, Franco EL, Tejada R, Vaccarella S. Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nature Reviews. Clinical Oncology. PMID 38760499 DOI: 10.1038/s41571-024-00904-z  0.474
2024 Ng K, Morais S, Wissing MD, Burchell AN, Tellier P-P, Coutlée F, Waterboer T, El-Zein M, Franco EL. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women. Microbiology Spectrum. e0022924. PMID 38687066 DOI: 10.1128/spectrum.00229-24  0.461
2024 Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H. Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes. Journal of Medical Virology. 96: e29608. PMID 38623750 DOI: 10.1002/jmv.29608  0.462
2024 Laurie C, El-Zein M, Tota JE, Tellier PP, Coutlée F, Burchell AN, Franco EL. Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial. Journal of Medical Virology. 96: e29604. PMID 38606779 DOI: 10.1002/jmv.29604  0.452
2024 Kassam P, El-Zein M, Laurie C, Tota JE, Tellier PP, Coutlée F, de Pokomandy A, Franco EL. Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men. Journal of Medical Virology. 96: e29562. PMID 38528834 DOI: 10.1002/jmv.29562  0.451
2024 Lehtinen M, Bruni L, Elfström M, Gray P, Logel M, Mariz FC, Baussano I, Vänskä S, Franco EL, Dillner J. Scientific approaches toward improving cervical cancer elimination strategies. International Journal of Cancer. PMID 38196123 DOI: 10.1002/ijc.34839  0.372
2023 Malagón T, Ribeiro AL, Montosa Nunes E, Gheit T, El-Zein M, Villa LL, Franco EL, Sichero L. Betapapillomavirus natural history and co-detection with alphapapillomavirus in cervical samples of adult women. Journal of Medical Virology. 95: e29288. PMID 38054528 DOI: 10.1002/jmv.29288  0.405
2023 Morais S, Wissing MD, Khosrow-Khavar F, Burchell AN, Tellier PP, Coutlée F, Waterboer T, El-Zein M, Franco EL. Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study. Infectious Diseases (London, England). 56: 66-72. PMID 37994805 DOI: 10.1080/23744235.2023.2277390  0.438
2023 Arthur AW, El-Zein M, Burchell AN, Tellier PP, Coutlée F, Franco EL. Epidemiology of genital human papillomavirus infections in sequential male sex partners of young females. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 37981060 DOI: 10.1016/j.cmi.2023.11.009  0.337
2023 Volesky-Avellaneda KD, Laurie C, Tsyruk-Romano O, El-Zein M, Franco EL. Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis. Obstetrics and Gynecology. 142: 1055-1067. PMID 37856917 DOI: 10.1097/AOG.0000000000005370  0.439
2023 Arthur AW, El-Zein M, Burchell AN, Tellier PP, Coutlée F, Franco EL. Detection and clearance of type-specific and phylogenetically related genital human papillomavirus infections in young women in new heterosexual relationships. The Journal of Infectious Diseases. PMID 37824429 DOI: 10.1093/infdis/jiad450  0.442
2023 Gottschlich A, Gondara L, Smith LW, Anderson JJ, Cook D, Krajden M, Lee M, Martin RE, Melnikow J, Peacock S, Proctor L, Stuart G, Franco EL, van Niekerk D, Ogilvie GS. Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study. Lancet Regional Health. Americas. 26: 100598. PMID 37786399 DOI: 10.1016/j.lana.2023.100598  0.417
2023 Volesky-Avellaneda KD, Laurie C, Tsyruk-Romano O, El-Zein M, Franco EL. Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis. Obstetrics and Gynecology. PMID 37712827 DOI: 10.1097/AOG.0000000000005370  0.439
2023 El-Zein M, Cheishvili D, Szyf M, Franco EL. Validation of novel DNA methylation markers in cervical precancer and cancer. International Journal of Cancer. PMID 37606371 DOI: 10.1002/ijc.34686  0.303
2023 Waheed DE, Olivier CW, Riethmuller D, Franco EL, Prétet JL, Baay M, Munoz N, Vorsters A. Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward - a meeting report. Bmc Proceedings. 17: 18. PMID 37537651 DOI: 10.1186/s12919-023-00271-0  0.458
2023 Laurie C, El-Zein M, Botting-Provost S, Tota JE, Tellier PP, Coutlée F, Burchell AN, Franco EL. Efficacy and safety of a self-applied carrageenan-based gel to prevent human papillomavirus infection in sexually active young women (CATCH study): an exploratory phase IIB randomised, placebo-controlled trial. Eclinicalmedicine. 60: 102038. PMID 37396806 DOI: 10.1016/j.eclinm.2023.102038  0.379
2023 Franco EL. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States. Cancer. PMID 37347988 DOI: 10.1002/cncr.34899  0.31
2023 Arthur AW, El-Zein M, Burchell AN, Tellier PP, Coutl E F, Franco EL. Detection and clearance of type-specific and phylogenetically related genital human papillomavirus infections in young women in new heterosexual relationships. Medrxiv : the Preprint Server For Health Sciences. PMID 36865299 DOI: 10.1101/2023.02.24.23286387  0.415
2023 Malagón T, Trottier H, El-Zein M, Villa LL, Franco EL. Human papillomavirus intermittence and risk factors associated with first detections and redetections in the Ludwig-McGill cohort study of adult women. The Journal of Infectious Diseases. PMID 36790831 DOI: 10.1093/infdis/jiad043  0.442
2022 Wang WV, Kothari S, Khoury H, Niccolai L, Garland SM, Sundström K, de Pouvourville G, Bonanni P, Chen YT, Franco EL. A review of data systems for assessing the impact of HPV vaccination in selected high-income countries. Expert Review of Vaccines. PMID 36576068 DOI: 10.1080/14760584.2023.2162505  0.358
2022 Morais S, Wissing MD, Khosrow-Khavar F, Burchell AN, Tellier PP, Coutlée F, Waterboer T, El-Zein M, Franco EL. Serologic response to human papillomavirus genotypes among unvaccinated females: Findings from the HITCH cohort study. The Journal of Infectious Diseases. PMID 36322543 DOI: 10.1093/infdis/jiac437  0.414
2022 Hurtado-Salgado E, Ortiz-Panozo E, Salmerón J, Luna-Gordillo R, Allen-Leigh B, Saavedra-Lara N, Franco EL, Lazcano-Ponce E. Prevalence of cervical human papillomavirus in Mexico, 2010-2017: analysis of 2.7 million women. Cancer Causes & Control : Ccc. PMID 36273050 DOI: 10.1007/s10552-022-01642-2  0.436
2022 El-Zein M, Bouten S, Abdrabo LS, Siblini A, Louvanto K, Franco E, Ferenczy A. Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions. Journal of Lower Genital Tract Disease. PMID 36205321 DOI: 10.1097/LGT.0000000000000706  0.46
2022 de Araujo-Souza PS, El-Zein M, Bolpetti ADN, Maciag PC, Rabachini T, Franco EL, Villa LL. Association between Human Leukocyte Antigen Polymorphism and Human Papillomavirus Infection in Brazilian Women. Sexually Transmitted Diseases. PMID 36194829 DOI: 10.1097/OLQ.0000000000001718  0.451
2022 Lesack A, Smith LW, Racey CS, Gondara L, Krajden M, Lee M, Martin RE, Stuart G, Peacock S, Franco EL, van Niekerk D, Ogilvie GS. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Current Oncology (Toronto, Ont.). 29: 3860-3869. PMID 35735417 DOI: 10.3390/curroncol29060308  0.43
2022 Gottschlich A, Gondara L, Smith LW, Cook D, Martin RE, Lee M, Peacock S, Proctor L, Stuart G, Krajden M, Franco EL, van Niekerk D, Ogilvie G. HPV-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV FOr CervicAL Cancer (HPV FOCAL) trial. International Journal of Cancer. PMID 35460070 DOI: 10.1002/ijc.34039  0.441
2022 Shapiro SB, Wissing MD, Khosrow-Khavar F, El-Zein M, Burchell AN, Tellier PP, Coutlée F, Franco EL. Male circumcision and genital human papillomavirus infection in males and their female sexual partners: findings from the HITCH cohort study. The Journal of Infectious Diseases. PMID 35429378 DOI: 10.1093/infdis/jiac147  0.322
2022 Tejada RA, Malagón T, Franco EL. Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis. Vaccine. 40: 2667-2678. PMID 35370017 DOI: 10.1016/j.vaccine.2022.03.046  0.325
2022 Louvanto K, Baral P, Burchell A, Ramanakumar A, El-Zein M, Tellier PP, Coutlée F, Roger M, Franco EL. Role of Human Leukocyte Antigen Allele Sharing in Human Papillomavirus Infection Transmission Among Heterosexual Couples: Findings From the Hitch Cohort Study. The Journal of Infectious Diseases. PMID 35363864 DOI: 10.1093/infdis/jiac115  0.328
2022 Logel M, Laurie C, El-Zein M, Guichon J, Franco EL. A review of ethical and legal aspects of gender-neutral human papillomavirus vaccination. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35247878 DOI: 10.1158/1055-9965.EPI-21-1256  0.341
2022 MacCosham A, El-Zein M, Burchell AN, Tellier PP, Coutlée F, Franco EL. Protection to self and to one's sexual partner after human papillomavirus vaccination: Preliminary analysis from the TRAP-HPV study. Sexually Transmitted Diseases. PMID 35235550 DOI: 10.1097/OLQ.0000000000001620  0.361
2022 Volesky KD, Magnan S, Mayrand MH, Isidean SD, El-Zein M, Comète E, Franco EL, Coutlée F. Clinical performance of the BD Onclarity extended genotyping assay for the management of women positive for human papillomavirus in cervical cancer screening. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35131879 DOI: 10.1158/1055-9965.EPI-21-1082  0.462
2022 Laurie C, El-Zein M, Tota J, Khosrow-Khavar F, Tellier PP, Coutlée F, de Pokomandy A, Franco EL. Efficacy of a carrageenan gel in increasing clearance of anal HPV infections in men: interim analysis of a double-blind randomized controlled trial. The Journal of Infectious Diseases. PMID 35090175 DOI: 10.1093/infdis/jiac019  0.459
2022 Coutlée F, Pokomandy A, Burchell AN, El-Zein M, Mayrand MH, Rodrigues-Coutlée S, Money D, Comète É, McClymont E, Rouleau D, Franco EL. Human Papillomavirus genotype concordance between Anyplex II HPV28 and Linear array HPV genotyping test in anogenital samples. Journal of Medical Virology. PMID 35060132 DOI: 10.1002/jmv.27605  0.451
2021 Hurtado-Salgado E, Cárdenas-Cárdenas L, Salmerón J, Luna-Gordillo R, Ortiz-Panozo E, Allen-Leigh B, Saavedra-Lara N, Franco EL, Lazcano-Ponce E. Comparative performance of the human papillomavirus test and cytology for primary screening for high-grade cervical intraepithelial neoplasia at the population level. International Journal of Cancer. 150: 1422-1430. PMID 34921727 DOI: 10.1002/ijc.33905  0.348
2021 Malagón T, MacCosham A, Burchell AN, El-Zein M, Tellier PP, Coutlée F, Franco EL. Proportion of incident genital human papillomavirus detections not attributable to transmission and potentially attributable to latent infections: Implications for cervical cancer screening. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34849640 DOI: 10.1093/cid/ciab985  0.44
2021 Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, Kupets R, Smith R, Arrossi S, Bendahhou K, Canfell K, Chirenje ZM, Chung MH, Del Pino M, de Sanjosé S, ... ... Franco EL, et al. The IARC Perspective on Cervical Cancer Screening. The New England Journal of Medicine. 385: 1908-1918. PMID 34758259 DOI: 10.1056/NEJMsr2030640  0.31
2021 Andrade Pessoa Morales J, Marconi C, El-Zein M, Ravel J, da Silva Pinto GV, Silveira R, de Lima MD, de Carvalho NS, Figueiredo Alves RR, de Lima Parada CMG, Morais Leite SH, Villa LL, Franco EL, Guimarães da Silva M. Vaginal microbiome components as correlates of cervical human papillomavirus infection. The Journal of Infectious Diseases. PMID 34718662 DOI: 10.1093/infdis/jiab547  0.424
2021 Smith LW, Racey CS, Gondara L, Krajden M, Lee M, Martin RE, Stuart G, Peacock S, Coldman AJ, Franco EL, van Niekerk D, Ogilvie GS. Women's acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results. Bmj Open. 11: e052084. PMID 34620663 DOI: 10.1136/bmjopen-2021-052084  0.437
2021 Laurie C, Tota JE, El-Zein M, Tellier PP, Coutlée F, Burchell AN, Franco EL. Design and methods for the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) study: A randomized controlled trial. Contemporary Clinical Trials. 110: 106560. PMID 34487919 DOI: 10.1016/j.cct.2021.106560  0.447
2021 Waheed DE, Schiller J, Stanley M, Franco EL, Poljak M, Kjaer SK, Del Pino M, van der Klis F, Schim van der Loeff MF, Baay M, Van Damme P, Vorsters A. Human papillomavirus vaccination in adults: impact, opportunities and challenges - a meeting report. Bmc Proceedings. 15: 16. PMID 34384438 DOI: 10.1186/s12919-021-00217-4  0.406
2021 Grimes DR, Corry EMA, Malagón T, O'Riain C, Franco EL, Brennan DJ. Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination. Jama Network Open. 4: e2115321. PMID 34190993 DOI: 10.1001/jamanetworkopen.2021.15321  0.433
2021 Laurie C, El-Zein M, Tota JE, Khosrow-Khavar F, Tellier PP, Coutlée F, de Pokomandy A, Franco EL. Efficacy of a carrageenan gel in preventing anal human papillomavirus (HPV) infection: interim analysis of the Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV) randomised controlled trial. Sexually Transmitted Infections. PMID 34140405 DOI: 10.1136/sextrans-2021-055009  0.454
2021 Strang THR, Gottschlich A, Cook DA, Smith LW, Gondara L, Franco EL, Niekerk DJV, Ogilvie GS, Krajden M. Long-term cervical precancer outcomes after a negative DNA- or RNA-based human papillomavirus result. American Journal of Obstetrics and Gynecology. PMID 34081897 DOI: 10.1016/j.ajog.2021.05.038  0.402
2021 Trevisan A, Wissing MD, Dagenais C, Forest P, Ramanakumar AV, Burchell AN, Franco EL, Coutlée F, Couillard M. Development and evaluation of a new non-competitive Luminex immunoassay detecting antibodies against human papillomavirus types 6, 11, 16 and 18. The Journal of General Virology. 102. PMID 34043499 DOI: 10.1099/jgv.0.001610  0.424
2021 Bonjour M, Charvat H, Franco EL, Piñeros M, Clifford GM, Bray F, Baussano I. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. The Lancet. Public Health. PMID 33864738 DOI: 10.1016/S2468-2667(21)00046-3  0.417
2021 Cromwell I, Smith LW, van der Hoek K, Hedden L, Coldman AJ, Cook D, Franco EL, Krajden M, Martin R, Lee MH, Stuart G, van Niekerk D, Ogilvie G, Peacock S. Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial. Cancer Medicine. PMID 33811457 DOI: 10.1002/cam4.3864  0.41
2021 Laurie C, El-Zein M, Franco EL, Coutlée F. Assessment of the possible inhibitory effect of carrageenan in human papillomavirus DNA testing by polymerase chain reaction amplification. Journal of Medical Virology. PMID 33760280 DOI: 10.1002/jmv.26963  0.391
2021 Malagón T, MacCosham A, Burchell AN, El-Zein M, Tellier PP, Coutlée F, Franco EL. Sex- and type-specific genital human papillomavirus transmission rates between heterosexual partners: a Bayesian reanalysis of the HITCH cohort. Epidemiology (Cambridge, Mass.). PMID 33625158 DOI: 10.1097/EDE.0000000000001324  0.37
2021 Malagón T, Volesky KD, Franco EL. Reply to: Comments on cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis. International Journal of Cancer. PMID 33567100 DOI: 10.1002/ijc.33510  0.352
2021 Laurie C, El-Zein M, Coutlée F, de Pokomandy A, Franco EL. Carrageenan as a preventive agent against human papillomavirus infection: a narrative review. Sexually Transmitted Diseases. PMID 33433173 DOI: 10.1097/OLQ.0000000000001363  0.43
2020 El-Zein M, Khosrow-Khavar F, Burchell AN, Tellier PP, Eintracht S, McNamara E, Coutlée F, Franco EL. Association of serum 25-hydroxyvitamin D with prevalence, incidence, and clearance of vaginal HPV infection in young women. The Journal of Infectious Diseases. PMID 33306088 DOI: 10.1093/infdis/jiaa758  0.398
2020 Gottschlich A, van Niekerk D, Smith LW, Gondara L, Melinikow J, Cook DA, Lee M, Stuart G, Martin RE, Peacock S, Franco EL, Coldman A, Krajden M, Ogilvie G. Assessing 10-year safety of a single negative HPV test for cervical cancer screening: Evidence from FOCAL-DECADE cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33082202 DOI: 10.1158/1055-9965.EPI-20-1177  0.472
2020 MacCosham A, El-Zein M, Burchell AN, Tellier PP, Coutlée F, Franco EL. Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples. Bmj Open. 10: e039383. PMID 32788190 DOI: 10.1136/bmjopen-2020-039383  0.436
2020 El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing (STAIN-IT) study. International Journal of Cancer. PMID 32781481 DOI: 10.1002/ijc.33250  0.451
2020 Castle PE, Pierz AJ, Adcock R, Aslam S, Basu PS, Belinson JL, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco EL, Gravitt PE, Isidean SD, Lin J, Mahmud SM, et al. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prevention Research (Philadelphia, Pa.). PMID 32655005 DOI: 10.1158/1940-6207.Capr-20-0182  0.485
2020 Malagón T, Franco EL. Invited Commentary: Rethinking Cervical Cancer Elimination in Terms of Lifetime Risk Rather Than Arbitrarily-Defined Age-Standardized Incidence Rates. American Journal of Epidemiology. PMID 32639520 DOI: 10.1093/aje/kwaa120  0.361
2020 Tota JE, Isidean SD, Franco EL. Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening. International Journal of Cancer. PMID 32588426 DOI: 10.1002/ijc.33178  0.353
2020 Vorsters A, Bosch FX, Bonanni P, Franco EL, Baay M, Simas C, Waheed DE, Castro C, Murillo R, Trujillo L, Wiesner C, Muñoz N. Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report. Bmc Proceedings. 14: 8. PMID 32577128 DOI: 10.1186/s12919-020-00192-2  0.441
2020 Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H, The Ludwig-McGill Study Group. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens. Journal of Medical Microbiology. PMID 32510304 DOI: 10.1099/Jmm.0.001213  0.449
2020 Malagón T, Volesky KD, Bouten S, Laprise C, El-Zein M, Franco EL. Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: systematic review and meta-analysis. International Journal of Cancer. PMID 32363604 DOI: 10.1002/ijc.33035  0.481
2020 Malagón T, Mayrand MH, Ogilvie G, Gotlieb WH, Blake J, Bouchard C, Franco EL, Kulasingam S. Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32332032 DOI: 10.1158/1055-9965.Epi-20-0190  0.305
2020 Laurie C, El-Zein M, Tota J, Tellier PP, Coutlée F, Franco E, de Pokomandy A. Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV): design and methods for a randomised controlled trial. Bmj Open. 10: e035113. PMID 32205376 DOI: 10.1136/bmjopen-2019-035113  0.466
2020 Tomita LY, Horta BL, da Silva LLS, Malta MB, Franco EL, Cardoso MA. Fruits and vegetables and cervical cancer: a systematic review and meta-analysis. Nutrition and Cancer. 1-13. PMID 32156167 DOI: 10.1080/01635581.2020.1737151  0.423
2020 Covert C, Kahn J, Ding L, Franco E, Brown D, Ermel A. 68. HPV Vaccine Effectiveness with Different Dosing Schedules in a Community Setting Journal of Adolescent Health. 66: S35-S36. DOI: 10.1016/J.Jadohealth.2019.11.071  0.417
2019 Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico. Jama Network Open. 2: e1915781. PMID 31747033 DOI: 10.1001/jamanetworkopen.2019.15781  0.447
2019 Malagón T, Louvanto K, Ramanakumar AV, Koushik A, Coutlée F, Franco EL. Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age. Gynecologic Oncology. PMID 31604665 DOI: 10.1016/J.Ygyno.2019.09.010  0.404
2019 Madathil S, Rousseau MC, Joseph L, Coutlée F, Schlecht NF, Franco E, Nicolau B. Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals. International Journal of Cancer. PMID 31584196 DOI: 10.1002/Ijc.32708  0.777
2019 Widdice LE, Bernstein DI, Franco EL, Ding L, Brown DR, Ermel AC, Higgins L, Kahn JA. Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction. Vaccine. PMID 31582269 DOI: 10.1016/J.Vaccine.2019.08.052  0.3
2019 Wissing MD, Burchell AN, El-Zein M, Tellier PP, Coutlée F, Franco EL. Vaccination of young women decreases human papillomavirus transmission in heterosexual couples: findings from the HITCH cohort study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31488413 DOI: 10.1158/1055-9965.EPI-19-0618  0.402
2019 Vorsters A, Bonanni P, Maltezou HC, Yarwood J, Brewer NT, Bosch FX, Hanley S, Cameron R, Franco EL, Arbyn M, Muñoz N, Kojouharova M, Pattyn J, Baay M, Karafillakis E, et al. The role of healthcare providers in HPV vaccination programs - A meeting report. Papillomavirus Research (Amsterdam, Netherlands). 100183. PMID 31476478 DOI: 10.1016/J.Pvr.2019.100183  0.375
2019 El-Zein M, Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, Colares de Borba P, Teixeira JC, Moscicki AB, Harper DM, Tyring SK, Ramjattan B, Dubin G, Franco EL. Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women. Sexually Transmitted Diseases. PMID 31464859 DOI: 10.1097/OLQ.0000000000001053  0.45
2019 Coldman AJ, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan DJ, Lee M, Elwood-Martin R, Gentile L, Peacock S, Stuart GC, Franco EL, Ogilvie GS. Disease Detection at the 48 Month Exit Round of the HPV FOCAL Cervical Cancer Screening Trial in Women Per-Protocol Eligible for Routine Screening. International Journal of Cancer. PMID 31245842 DOI: 10.1002/Ijc.32524  0.411
2019 Volesky KD, El-Zein M, Franco EL, Brenner DR, Friedenreich CM, Ruan Y. Estimates of the future burden of cancer attributable to infections in Canada. Preventive Medicine. 122: 118-127. PMID 31078165 DOI: 10.1016/j.ypmed.2019.04.006  0.34
2019 Volesky KD, El-Zein M, Franco EL, Brenner DR, Friedenreich CM, Ruan Y. Cancers attributable to infections in Canada. Preventive Medicine. 122: 109-117. PMID 31078164 DOI: 10.1016/j.ypmed.2019.03.035  0.32
2019 Wissing MD, Louvanto K, Comète E, Burchell AN, El-Zein M, Rodrigues A, Tellier PP, Coutlée F, Franco EL. Human papillomavirus viral load and transmission in young, recently-formed heterosexual couples. The Journal of Infectious Diseases. PMID 31063542 DOI: 10.1093/infdis/jiz238  0.374
2019 El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, Behr MA, Franco EL. Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31015201 DOI: 10.1158/1055-9965.EPI-18-1338  0.41
2019 ThekkePurakkal AS, Nicolau B, Burk RD, Franco EL, Schlecht NF. Genetic variants in CYP and GST genes, smoking and risk for head and neck cancers: a gene-environment interaction hospital-based case-control study among Canadian Caucasians. Carcinogenesis. PMID 30938417 DOI: 10.1093/carcin/bgz051  0.588
2019 Sichero L, El-Zein M, Ferreira S, Franco EL, Villa LL. Lack of association between human papillomavirus types 6 and 11 genetic variants and cervical abnormalities: The Ludwig-McGill cohort study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30867221 DOI: 10.1158/1055-9965.EPI-19-0114  0.397
2019 Malagón T, Louvanto K, Wissing M, Burchell AN, Tellier PP, El-Zein M, Coutlée F, Franco EL. Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study. The Lancet. Infectious Diseases. PMID 30745276 DOI: 10.1016/S1473-3099(18)30655-8  0.334
2019 Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA. Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Pediatrics. PMID 30670582 DOI: 10.1542/peds.2018-1902  0.302
2019 El-Zein M, Coutlée F, Tellier PP, Roger M, Franco EL, Burchell AN. Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals. Jmir Research Protocols. 8: e11284. PMID 30650383 DOI: 10.2196/11284  0.379
2019 Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Human Vaccines & Immunotherapeutics. PMID 30633598 DOI: 10.1080/21645515.2018.1564438  0.373
2019 Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B. Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study. Head & Neck. PMID 30605251 DOI: 10.1002/Hed.25436  0.754
2019 Smith L, Niekerk DV, Krajden M, Gondara L, Cook D, Lee M, Martin R, Stuart G, Peacock S, Franco E, Coldman A, Ogilvie G. O17.2 Women’s experiences with primary human papillomavirus (HPV) testing for cervix screening: HPV focal exit survey results Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.200  0.542
2019 Ogilvie G, Niekerk DV, Krajden M, Smith L, Cook D, Martin R, Stuart G, Ceballos K, Lee M, Peacock S, Franco E, Coldman A. O17.1 HPV focal 48 month exit results by age for women HPV or LBC negative at baseline screening Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.199  0.545
2018 Gauthier B, Cerigo H, Coutlée F, Franco EL, Brassard P. Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada. International Journal of Circumpolar Health. 77: 1556556. PMID 30827197 DOI: 10.1080/22423982.2018.1556556  0.476
2018 Hurtado-Salgado E, Ortiz-Panozo E, Salmerón J, Saavedra-Lara N, Kuri-Morales P, Pesqueira-Villegas E, Luna-Gordillo R, Franco EL, Lazcano-Ponce E. Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study. Salud Publica De Mexico. 60: 722-733. PMID 30699277 DOI: 10.21149/9891  0.43
2018 Franco EL. Prevention of cervical cancer in Latin America: Future challenges and opportunities. Salud Publica De Mexico. 60: 609-611. PMID 30699263 DOI: 10.21149/  0.328
2018 Isidean SD, Wang Y, Mayrand MH, Ratnam S, Coutlée F, Franco EL, Abrahamowicz M. Assessing the Time Dependence of Prognostic Values of Cytology and Human Papillomavirus Testing in Cervical Cancer Screening. International Journal of Cancer. PMID 30411802 DOI: 10.1002/Ijc.31970  0.461
2018 Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study. The Lancet. Oncology. PMID 30392810 DOI: 10.1016/S1470-2045(18)30536-9  0.359
2018 Cook DA, Smith LW, Law JH, Mei W, Gondara L, van Niekerk DJ, Ceballos KM, Jang D, Chernesky M, Franco EL, Ogilvie GS, Coldman AJ, Krajden M. Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 108: 32-37. PMID 30223252 DOI: 10.1016/J.Jcv.2018.09.004  0.426
2018 Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, et al. HLA and KIR Associations of Cervical Neoplasia. The Journal of Infectious Diseases. PMID 30099516 DOI: 10.1093/Infdis/Jiy483  0.333
2018 Chandler E, Ding L, Gorbach P, Franco EL, Brown DA, Widdice LE, Bernstein DI, Kahn JA. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 63: 43-49. PMID 30060856 DOI: 10.1016/J.Jadohealth.2018.01.005  0.334
2018 Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial. Jama. 320: 43-52. PMID 29971397 DOI: 10.1001/Jama.2018.7464  0.449
2018 Malagón T, Laurie C, Franco EL. Human papillomavirus vaccination and the role of herd effects in future cancer control planning: A review. Expert Review of Vaccines. PMID 29715059 DOI: 10.1080/14760584.2018.1471986  0.386
2018 Magnan S, Tota JE, El-Zein M, Burchell AN, Schiller JT, Ferenczy A, Tellier PP, Coutlée F, Franco EL. Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): Interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 29684633 DOI: 10.1016/j.cmi.2018.04.012  0.427
2018 El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb W, Hemmings R, Behr MA, Franco EL, Liang V, Martins C, Duarte S, Sarban N, Geddes P, Massa A, et al. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study. Gynecologic Oncology. PMID 29678360 DOI: 10.1016/j.ygyno.2018.04.004  0.309
2018 Jha P, Franco E, Sankaranarayanan R, Rabeneck L, Gelband H. Integrated prevention for global cancer control The Lancet Global Health. 6: S8. DOI: 10.1016/S2214-109X(18)30084-6  0.302
2017 Farsi NJ, Rousseau MC, Schlecht N, Castonguay G, Allison P, Nguyen-Tan PF, Soulieres D, Coutlée F, Hier M, Madathil S, Franco EL, Nicolau B. Aetiological Heterogeneity of Head and Neck Squamous Cell Carcinomas: The Role of Human Papillomavirus Infections, Smoking, and Alcohol. Carcinogenesis. PMID 29029021 DOI: 10.1093/Carcin/Bgx106  0.758
2017 Malagón T, Burchell AN, El-Zein M, Guénoun J, Tellier PP, Coutlée F, Franco EL. Estimating HPV DNA deposition between sexual partners using HPV concordance, Y chromosome DNA detection, and self-reported sexual behaviours. The Journal of Infectious Diseases. PMID 28968731 DOI: 10.1093/infdis/jix477  0.378
2017 Smith C, Ding L, Gorbach PM, Franco EL, Kahn JA. Who's not protected in the herd? Factors associated with vaccine-type HPV in unvaccinated women. Journal of Pediatric and Adolescent Gynecology. PMID 28943220 DOI: 10.1016/j.jpag.2017.09.008  0.354
2017 Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, et al. Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. Plos Genetics. 13: e1006866. PMID 28806749 DOI: 10.1371/Journal.Pgen.1006866  0.423
2017 Ogilvie G, Nakisige C, Huh WK, Mehrotra R, Franco EL, Jeronimo J. Optimizing secondary prevention of cervical cancer: Recent advances and future challenges. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 138: 15-19. PMID 28691338 DOI: 10.1002/Ijgo.12187  0.453
2017 Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B. Human papillomavirus genotypes and risk of head and neck cancers: Results from the HeNCe Life case-control study. Oral Oncology. 69: 56-61. PMID 28559021 DOI: 10.1016/j.oraloncology.2017.03.013  0.763
2017 Smith L, van Niekerk D, Coldman A, Krajden M, Franco EL, Ogilvie G. Independent Scientists Provide Guidance for the Future of Cervical Cancer Screening. Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'Obstetrique Et Gynecologie Du Canada : Jogc. 39: 326-327. PMID 28454754 DOI: 10.1016/J.Jogc.2017.02.006  0.314
2017 Sichero L, El-Zein M, Nunes EM, Ferreira S, Franco EL, Villa LL. Cervical Infection with Cutaneous Beta and Mucosal Alpha Papillomaviruses. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28377417 DOI: 10.1158/1055-9965.EPI-17-0081  0.401
2017 Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Preventive Medicine. 98: 5-14. PMID 28279264 DOI: 10.1016/J.Ypmed.2016.11.029  0.455
2017 Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S. Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Preventive Medicine. 98: 15-20. PMID 28279257 DOI: 10.1016/J.Ypmed.2016.11.030  0.462
2017 Isidean SD, Mayrand MH, Ramanakumar AV, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL. COMPARISON OF TRIAGE STRATEGIES FOR HPV POSITIVE WOMEN: CANADIAN CERVICAL CANCER SCREENING TRIAL RESULTS. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28096198 DOI: 10.1158/1055-9965.EPI-16-0705  0.473
2017 Saccucci M, Ding L, Franco E, Bernstein DI, Brown D, Kahn JA. Epidemiologic Trends in Non-Vaccine-Type HPV After Vaccine Introduction: No Evidence For Type Replacement but Evidence for Cross-Protection Journal of Adolescent Health. 60. DOI: 10.1016/J.Jadohealth.2016.10.056  0.395
2016 Tota JE, Jiang M, Ramanakumar AV, Walter SD, Kaufman JS, Coutlée F, Richardson H, Burchell AN, Koushik A, Mayrand MH, Villa LL, Franco EL. Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination. Plos One. 11: e0166329. PMID 28005904 DOI: 10.1371/Journal.Pone.0166329  0.333
2016 Cook DA, Smith LW, Law J, Mei W, van Niekerk DJ, Ceballos K, Gondara L, Franco EL, Coldman AJ, Ogilvie GS, Jang D, Chernesky M, Krajden M. Aptima HPV Assay versus Hybrid Capture(®) 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 87: 23-29. PMID 27988420 DOI: 10.1016/J.Jcv.2016.12.004  0.463
2016 Coldman AJ, Gondara L, Smith LW, van Niekerk D, Ceballos K, Krajden M, Cook D, Quinlan DJ, Lee M, Stuart GC, Peacock S, Martin RE, Gentile L, Franco EL, Ogilvie GS. Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial. British Journal of Cancer. PMID 27855441 DOI: 10.1038/Bjc.2016.368  0.45
2016 Whittemore D, Ding L, Widdice LE, Brown DA, Bernstein DI, Franco EL, Kahn JA. Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women. Journal of Women's Health (2002). PMID 27754751 DOI: 10.1089/jwh.2015.5674  0.357
2016 Ogilvie GS, Krajden M, van Niekerk D, Smith LW, Cook D, Ceballos K, Lee M, Gentile L, Gondara L, Elwood-Martin R, Peacock S, Stuart G, Franco EL, Coldman AJ. HPV For Cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid based cytology for cervical cancer. International Journal of Cancer. PMID 27685757 DOI: 10.1002/Ijc.30454  0.472
2016 Kahn JA, Widdice LE, Ding L, Huang B, Brown DR, Franco EL, Bernstein DI. Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27655996 DOI: 10.1093/Cid/Ciw533  0.353
2016 Smith L, van Niekerk D, Coldman A, Krajden M, Franco EL, Ogilvie G. Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial. Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'Obstetrique Et Gynecologie Du Canada : Jogc. 38: 723-726. PMID 27638983 DOI: 10.1016/J.Jogc.2016.04.009  0.412
2016 Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Lazcano-Ponce E, Torres-Ibarra L, León-Maldonado L, Ramírez P, Rivera B, Hernández R, Franco EL, Cuzick J, Méndez-Hernández P, Salmerón J. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico. Bmc Infectious Diseases. 16: 461. PMID 27585544 DOI: 10.1186/S12879-016-1782-X  0.499
2016 Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, de Borba PC, Teixeira JC, Blatter M, Moscicki AB, Harper DM, Romanowski B, Tyring SK, Ramjattan B, Schuind A, Dubin G, Franco EL, et al. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial. Bmj Open. 6: e011371. PMID 27566633 DOI: 10.1136/bmjopen-2016-011371  0.468
2016 Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, Rivera B, Ramírez P, Mendiola-Pastrana I, Rudolph SE, León-Maldonado L, Hernández R, Barrios E, Gravitt P, Moscicki AB, et al. Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study. Salud PúBlica De MéXico. 58: 197-210. PMID 27557378 DOI: 10.21149/Spm.V58I2.7789  0.397
2016 Isidean SD, Mayrand MH, Ramanakumar AV, Gilbert L, Reid SL, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL, Abruzzese L, Steben M. Human Papillomavirus Testing versus Cytology in Primary Cervical Cancer Screening: End-of-Study and Extended Follow-Up Results from the Canadian Cervical Cancer Screening Trial (CCCaST). International Journal of Cancer. PMID 27538188 DOI: 10.1002/ijc.30385  0.483
2016 Madathil SA, Rousseau MC, Wynant W, Schlecht NF, Netuveli G, Franco EL, Nicolau B. Nonlinear association between betel quid chewing and oral cancer: Implications for prevention. Oral Oncology. 60: 25-31. PMID 27531869 DOI: 10.1016/j.oraloncology.2016.06.011  0.745
2016 Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Coutlée F, Franco EL. Cervical Infection with Vaccine Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections. The Journal of Infectious Diseases. PMID 27256157 DOI: 10.1093/infdis/jiw215  0.425
2016 Tota JE, Isidean SD, Franco EL. Should we lower the age for routine HPV vaccination in the United States? Preventive Medicine. PMID 27240451 DOI: 10.1016/j.ypmed.2016.05.027  0.325
2016 Laprise C, Puthiyannal Shahul H, Arekunnath Madathil S, Soman Thekkepurakkal A, Castonguay G, Varghese I, Shiraz S, Allison P, Schlecht NF, Rousseau MC, Franco EL, Nicolau B. Periodontal diseases and risk of oral cancer in Southern India: Results from the HeNCe Life study. International Journal of Cancer. PMID 27215979 DOI: 10.1002/ijc.30201  0.686
2016 Shaw E, Ramanakumar AV, El-Zein M, Silva FR, Galan L, Baggio ML, Villa LL, Franco EL. Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study. Bmc Infectious Diseases. 16: 116. PMID 26956880 DOI: 10.1186/s12879-016-1446-x  0.467
2016 Ogilvie GS, Smith LW, van Niekerk D, Khurshed F, Pedersen HN, Taylor D, Thomson K, Greene SB, Babich SM, Franco EL, Coldman AJ. Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval. Bmc Public Health. 16: 213. PMID 26935960 DOI: 10.1186/S12889-016-2865-8  0.434
2016 Madathil SA, Rousseau MC, Wynant W, Schlecht NF, Netuveli G, Franco EL, Nicolau B. Nonlinear association between betel quid chewing and oral cancer: Implications for prevention Oral Oncology. 60: 25-31. DOI: 10.1016/j.oraloncology.2016.06.011  0.632
2016 Smith L, Krajden M, van Niekerk D, Coldman A, Franco E, Ogilvie G. P-GYN-ONCOL-RN-042 The HPV Focal Study: What Participants and Healthcare Providers Want to Know about HPV Testing Journal of Obstetrics and Gynaecology Canada. 38: 500. DOI: 10.1016/J.Jogc.2016.04.069  0.519
2015 Gauthier B, Coutlée F, Franco EL, Brassard P. Human papillomavirus variants among Inuit women in northern Quebec, Canada. International Journal of Circumpolar Health. 74: 29482. PMID 28417802 DOI: 10.3402/ijch.v74.29482  0.47
2015 Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, Forhan SE, Franco EL, Gage JC, Garcia F, Herrero R, et al. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 26868062 DOI: 10.1016/J.Ijgo.2015.07.038  0.381
2015 Cook DA, Mei W, Smith LW, van Niekerk DJ, Ceballos K, Franco EL, Coldman AJ, Ogilvie GS, Krajden M. Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial. Bmc Cancer. 15: 968. PMID 26674353 DOI: 10.1186/S12885-015-1959-5  0.474
2015 Gauthier B, Coutlée F, Franco EL, Brassard P. Human papillomavirus variants among Inuit women in northern Quebec, Canada. International Journal of Circumpolar Health. 74: 29482. PMID 26653084 DOI: 10.3402/ijch.v74.29482  0.468
2015 El-Zein M, Richardson L, Franco EL. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. PMID 26631958 DOI: 10.1016/j.jcv.2015.11.020  0.436
2015 Lemieux-Mellouki P, Drolet M, Brisson J, Franco EL, Boily MC, Baussano I, Brisson M. Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus. Epidemiology and Infection. 1-10. PMID 26584685 DOI: 10.1017/S0950268815002915  0.356
2015 Trottier H, Mayrand MH, Baggio ML, Galan L, Ferenczy A, Villa LL, Franco EL. Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy. Bmc Pregnancy and Childbirth. 15: 244. PMID 26446835 DOI: 10.1186/s12884-015-0675-0  0.469
2015 Laprise C, Madathil SA, Allison P, Abraham P, Raghavendran A, Shahul HP, ThekkePurakkal AS, Castonguay G, Coutlée F, Schlecht NF, Rousseau MC, Franco EL, Nicolau B. No role for human papillomavirus infection in oral cancers in a region in southern India. International Journal of Cancer. Journal International Du Cancer. PMID 26317688 DOI: 10.1002/ijc.29827  0.779
2015 Richardson LA, El-Zein M, Ramanakumar AV, Ratnam S, Sangwa-Lugoma G, Longatto-Filho A, Cardoso MA, Coutlée F, Franco EL. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status. Cancer Cytopathology. PMID 26230283 DOI: 10.1002/cncy.21596  0.47
2015 Coldman AJ, Phillips N, van Niekerk D, Smith L, Krajden M, Cook D, Quinlan DJ, Ehlen T, Miller D, Stuart GCE, Peacock S, Elwood Martin R, Franco EL, Ogilvie G. Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'ObstéTrique Et GynéCologie Du Canada : Jogc. 37: 412-420. PMID 26168101 DOI: 10.1016/S1701-2163(15)30255-3  0.306
2015 Bennett R, Cerigo H, Coutlée F, Roger M, Franco EL, Brassard P. Incidence, persistence, and determinants of human papillomavirus infection in a population of Inuit women in northern Quebec. Sexually Transmitted Diseases. 42: 272-8. PMID 25868140 DOI: 10.1097/OLQ.0000000000000272  0.409
2015 Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Gynecologic Oncology. 137: 47-54. PMID 25667973 DOI: 10.1016/j.ygyno.2015.01.551  0.382
2015 Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Koushik A, Mayrand MH, Coutlée F, Franco EL. Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 286-90. PMID 25277793 DOI: 10.1158/1055-9965.Epi-14-0566  0.463
2015 Isidean SD, Tota JE, Gagnon JA, Franco EL. Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs. Expert Review of Vaccines. 14: 119-33. PMID 25266065 DOI: 10.1586/14760584.2015.964213  0.355
2015 Louvanto K, Franco EL, Ramanakumar AV, Vasiljevi? N, Scibior-Bentkowska D, Koushik A, Cuzick J, Coutlée F, Lorincz AT. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. International Journal of Cancer. Journal International Du Cancer. 136: E638-45. PMID 25203794 DOI: 10.1002/Ijc.29196  0.383
2015 Trottier H, Mayrand MH, Baggio ML, Galan L, Ferenczy A, Villa LL, Franco EL. Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy Bmc Pregnancy and Childbirth. DOI: 10.1186/s12884-015-0675-0  0.447
2014 de Araujo-Souza PS, Ramanakumar AV, Candeias JM, Thomann P, Trevisan A, Franco EL, Villa LL. Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study. Bmc Infectious Diseases. 14: 578. PMID 25730386 DOI: 10.1186/s12879-014-0578-0  0.468
2014 Spence AR, Alobaid A, Drouin P, Goggin P, Gilbert L, Provencher D, Tousignant P, Hanley JA, Franco EL. Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec. Current Oncology (Toronto, Ont.). 21: 294-304. PMID 25489256 DOI: 10.3747/Co.21.2056  0.618
2014 Dahlstrom KR, Burchell AN, Ramanakumar AV, Rodrigues A, Tellier PP, Hanley J, Coutlée F, Franco EL. Sexual transmission of oral human papillomavirus infection among men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2959-64. PMID 25392180 DOI: 10.1158/1055-9965.EPI-14-0386  0.45
2014 Smith LW, Khurshed F, van Niekerk DJ, Krajden M, Greene SB, Hobbs S, Coldman AJ, Franco EL, Ogilvie GS. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program. Bmc Public Health. 14: 1060. PMID 25303975 DOI: 10.1186/1471-2458-14-1060  0.408
2014 Jelen MM, Chen Z, Kocjan BJ, Burt FJ, Chan PK, Chouhy D, Combrinck CE, Coutlée F, Estrade C, Ferenczy A, Fiander A, Franco EL, Garland SM, Giri AA, González JV, et al. Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. Journal of Virology. 88: 7307-16. PMID 24741079 DOI: 10.1128/JVI.00621-14  0.356
2014 Burchell AN, Rodrigues A, Moravan V, Tellier PP, Hanley J, Coutlée F, Franco EL. Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis. The Journal of Infectious Diseases. 210: 846-52. PMID 24683197 DOI: 10.1093/infdis/jiu200  0.356
2014 Smith MA, Tellier PP, Roger M, Coutlée F, Franco EL, Richardson H. Determinants of human papillomavirus coinfections among Montreal university students: the influence of behavioral and biologic factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 812-22. PMID 24569438 DOI: 10.1158/1055-9965.EPI-13-1255  0.44
2014 Louvanto K, Chevarie-Davis M, Ramanakumar AV, Franco EL, Ferenczy A. HPV testing with cytology triage for cervical cancer screening in routine practice. American Journal of Obstetrics and Gynecology. 210: 474.e1-7. PMID 24373948 DOI: 10.1016/j.ajog.2013.12.033  0.396
2014 Isidean SD, Coutlée F, Franco EL. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens. Expert Review of Molecular Diagnostics. 14: 5-16. PMID 24308341 DOI: 10.1586/14737159.2014.865521  0.467
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Franco EL, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: H1-31. PMID 24332295 DOI: 10.1016/j.vaccine.2013.10.003  0.486
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Franco EL, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: G1-31. PMID 24331817 DOI: 10.1016/j.vaccine.2013.10.002  0.486
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Franco EL, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: F1-31. PMID 24331745 DOI: 10.1016/j.vaccine.2013.10.001  0.486
2013 Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Franco EL, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: I1-31. PMID 24229716 DOI: 10.1016/J.Vaccine.2013.07.026  0.486
2013 Rodrigues-Coutlée C, Archambault J, Money D, Ramanakumar AV, Raboud J, Hankins C, Koushik A, Richardson H, Brassard P, Franco EL, Coutlée F. Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 58: 660-5. PMID 24210329 DOI: 10.1016/J.Jcv.2013.10.015  0.451
2013 Metcalfe S, Roger M, Faucher MC, Coutlée F, Franco EL, Brassard P. The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec. Human Immunology. 74: 1610-5. PMID 23994586 DOI: 10.1016/j.humimm.2013.08.279  0.341
2013 Drolet M, Boily MC, Van de Velde N, Franco EL, Brisson M. Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness? Plos One. 8: e67072. PMID 23840589 DOI: 10.1371/Journal.Pone.0067072  0.378
2013 Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Vaccine. 31: 3863-71. PMID 23830974 DOI: 10.1016/J.Vaccine.2013.06.064  0.315
2013 Ogilvie GS, Smith LW, van Niekerk DJ, Khurshed F, Krajden M, Saraiya M, Goel V, Rimer BK, Greene SB, Hobbs S, Coldman AJ, Franco EL. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing. International Journal of Cancer. Journal International Du Cancer. 133: 2934-43. PMID 23754203 DOI: 10.1002/Ijc.28324  0.416
2013 Trevisan A, Schlecht NF, Ramanakumar AV, Villa LL, Franco EL. Human papillomavirus type 16 viral load measurement as a predictor of infection clearance. The Journal of General Virology. 94: 1850-7. PMID 23677791 DOI: 10.1099/vir.0.051722-0  0.676
2013 Oliveira LB, Louvanto K, Ramanakumar AV, Franco EL, Villa LL. Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection. The Journal of General Virology. 94: 1858-64. PMID 23677790 DOI: 10.1099/vir.0.052811-0  0.416
2013 Tota JE, Ramanakumar AV, Jiang M, Dillner J, Walter SD, Kaufman JS, Coutlée F, Villa LL, Franco EL. Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. American Journal of Epidemiology. 178: 625-34. PMID 23660798 DOI: 10.1093/Aje/Kwt018  0.425
2013 Cerigo H, Coutlée F, Franco EL, Brassard P. Factors associated with cervical cancer screening uptake among Inuit women in Nunavik, Quebec, Canada. Bmc Public Health. 13: 438. PMID 23642072 DOI: 10.1186/1471-2458-13-438  0.314
2013 Tota JE, Ramanakumar AV, Mahmud SM, Trevisan A, Villa LL, Franco EL. Cervical human papillomavirus detection is not affected by menstrual phase. Sexually Transmitted Infections. 89: 202-6. PMID 23112338 DOI: 10.1136/sextrans-2012-050610  0.455
2013 Formentin A, Archambault J, Koushik A, Richardson H, Brassard P, Franco EL, Coutlée F. Human papillomavirus type 52 polymorphism and high-grade lesions of the uterine cervix. International Journal of Cancer. 132: 1821-30. PMID 23015309 DOI: 10.1002/Ijc.27874  0.474
2013 Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, Franco EL, Poole C, Smith JS. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. International Journal of Cancer. Journal International Du Cancer. 133: 1271-85. PMID 22961444 DOI: 10.1002/Ijc.27828  0.476
2013 Sangwa-Lugoma G, Ramanakumar AV, Mahmud S, Liaras J, Kayembe PK, Tozin RR, Lorincz A, Franco EL. Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community. Sexually Transmitted Diseases. 38: 308-15. PMID 21150817 DOI: 10.1097/OLQ.0b013e3181fc6ec0  0.463
2013 Ogilvie G, Smith L, Niekerk Dv, Khurshed F, Greene S, Hobbs S, Coldman A, Franco E. O10.3 Predictors of Women’s Intentions to Receive Cervical Cancer Screening with Primary HPV Testing Sexually Transmitted Infections. 89: A44.4-A45. DOI: 10.1136/Sextrans-2013-051184.0139  0.54
2013 Ogilvie G, Krajden M, Ehlen T, Martin R, Smith L, Peacock S, Stuart GCE, Franco EL, Coldman AJ. O10.1 Age Specific Round 1 Results of a Cervical Cancer Screening Trial: HPV FOCAL Sexually Transmitted Infections. 89: A44.2-A44. DOI: 10.1136/Sextrans-2013-051184.0137  0.458
2013 Franco EL. PL01.2 HPV: Changing Screening Algorithms and Scaling Up Vaccination Sexually Transmitted Infections. 89: A2.2-A2. DOI: 10.1136/sextrans-2013-051184.0003  0.314
2012 Cerigo H, Ellen Macdonald M, Franco EL, Brassard P. Inuit women's attitudes and experiences towards cervical cancer and prevention strategies in Nunavik, Quebec. International Journal of Circumpolar Health. 71: 17996. PMID 28417747 DOI: 10.3402/ijch.v71i0.17996  0.414
2012 Franco EL, de Sanjosé S, Broker TR, Stanley MA, Chevarie-Davis M, Isidean SD, Schiffman M. Human papillomavirus and cancer prevention: Gaps in knowledge and prospects for research, policy, and advocacy Vaccine. 30: F175-F182. PMID 23199961 DOI: 10.1016/J.Vaccine.2012.06.092  0.458
2012 Ogilvie GS, Krajden M, van Niekerk DJ, Martin RE, Ehlen TG, Ceballos K, Smith LW, Kan L, Cook DA, Peacock S, Stuart GC, Franco EL, Coldman AJ. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study. British Journal of Cancer. 107: 1917-24. PMID 23169286 DOI: 10.1038/bjc.2012.489  0.461
2012 Landry ME, Salit IE, Rodrigues-Coutlée C, Money D, Rebbapragada A, Tinmouth J, Hankins C, Gorska-Flipot I, Archambault J, Franco EL, Coutlée F. Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus. Virology Journal. 9: 243. PMID 23092191 DOI: 10.1186/1743-422X-9-243  0.396
2012 Coutlée F, de Pokomandy A, Franco EL. Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sexual Health. 9: 547-55. PMID 22954036 DOI: 10.1071/SH11167  0.392
2012 Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 12: 781-9. PMID 22920953 DOI: 10.1016/S1473-3099(12)70187-1  0.319
2012 Cerigo H, Macdonald ME, Franco EL, Brassard P. Inuit women's attitudes and experiences towards cervical cancer and prevention strategies in Nunavik, Quebec. International Journal of Circumpolar Health. 71: 17996. PMID 22456050 DOI: 10.3402/ijch.v71i0.17996  0.414
2012 Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American Journal of Clinical Pathology. 137: 516-42. PMID 22431528 DOI: 10.1309/Ajcptgd94Evrsjcg  0.372
2012 Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Ca: a Cancer Journal For Clinicians. 62: 147-72. PMID 22422631 DOI: 10.3322/Caac.21139  0.372
2012 Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Journal of Lower Genital Tract Disease. 16: 175-204. PMID 22418039 DOI: 10.1097/Lgt.0B013E31824Ca9D5  0.349
2012 Lapierre SG, Sauthier P, Mayrand MH, Dufresne S, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis MJ, Michon B, Ouellet S, Hadjeres R, Ferenczy A, Franco EL, Coutlée F. Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. Journal of Clinical Microbiology. 50: 1240-4. PMID 22301023 DOI: 10.1128/JCM.06656-11  0.463
2012 Ferguson R, Ramanakumar AV, Koushik A, Coutlée F, Franco E, Roger M. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. International Journal of Cancer. 131: E312-9. PMID 22095460 DOI: 10.1002/Ijc.27356  0.514
2012 Mahmud SM, Sangwa-Lugoma G, Nasr SH, Kayembe PK, Tozin RR, Drouin P, Lorincz A, Ferenczy A, Franco EL. Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo. Gynecologic Oncology. 124: 286-91. PMID 22062546 DOI: 10.1016/j.ygyno.2011.10.031  0.418
2012 Siegel EM, Patel N, Lu B, Lee JH, Nyitray AG, Craft NE, Frenkel K, Villa LL, Franco EL, Giuliano AR. Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response? International Journal of Cancer. Journal International Du Cancer. 131: 219-28. PMID 21858808 DOI: 10.1002/Ijc.26363  0.457
2011 Richardson LA, Tota J, Franco EL. Optimizing technology for cervical cancer screening in high-resource settings. Expert Review of Obstetrics & Gynecology. 6: 343-353. PMID 26617667 DOI: 10.1586/eog.11.13  0.467
2011 Petermann L, McLean D, Stuart G, Sherman M, Franco E. Meeting report: National symposium on infectious agents and cancer. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 22: e16. PMID 22942889 DOI: 10.1155/2011/820298  0.417
2011 Burchell AN, Coutlée F, Tellier PP, Hanley J, Franco EL. Genital transmission of human papillomavirus in recently formed heterosexual couples. The Journal of Infectious Diseases. 204: 1723-9. PMID 21984739 DOI: 10.1093/infdis/jir644  0.424
2011 Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Preventive Medicine. 53: S12-21. PMID 21962466 DOI: 10.1016/j.ypmed.2011.08.017  0.485
2011 Legault V, Burchell A, Goggin P, Nicolau B, Brassard P, Guenoun J, Forest P, Mayrand MH, Franco EL, Coutlée F. Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR. Journal of Clinical Microbiology. 49: 3977-9. PMID 21940471 DOI: 10.1128/JCM.05646-11  0.391
2011 Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Journal of Medical Virology. 83: 1034-41. PMID 21503917 DOI: 10.1002/Jmv.22081  0.469
2011 Sénécal M, Brisson M, Maunsell E, Ferenczy A, Franco EL, Ratnam S, Coutlée F, Palefsky JM, Mansi JA. Loss of quality of life associated with genital warts: baseline analyses from a prospective study. Sexually Transmitted Infections. 87: 209-15. PMID 21335602 DOI: 10.1136/Sti.2009.039982  0.417
2011 Ferguson R, Ramanakumar AV, Richardson H, Tellier PP, Coutlée F, Franco EL, Roger M. Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Human Immunology. 72: 337-41. PMID 21256910 DOI: 10.1016/j.humimm.2011.01.010  0.362
2011 Mayrand MH, Franco EL. Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control. Future Oncology (London, England). 6: 1725-33. PMID 21142659 DOI: 10.2217/fon.10.141  0.471
2011 Dufresne S, Sauthier P, Mayrand MH, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis MJ, Michon B, Ouellet S, Hadjeres R, Ferenczy A, Franco EL, Coutlée F. Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix. Journal of Clinical Microbiology. 49: 48-53. PMID 21084508 DOI: 10.1128/JCM.01063-10  0.46
2011 Vanni T, Legood R, Franco EL, Villa LL, Luz PM, Schwartsmann G. Economic evaluation of strategies for managing women with equivocal cytological results in Brazil International Journal of Cancer. 129: 671-679. PMID 20886598 DOI: 10.1002/Ijc.25708  0.35
2011 Cerigo H, Macdonald ME, Franco EL, Brassard P. Awareness and knowledge about human papillomavirus among Inuit women in Nunavik, Quebec. Journal of Community Health. 36: 56-62. PMID 20517640 DOI: 10.1007/s10900-010-9278-x  0.476
2011 Richardson LA, Tota J, Franco EL. Optimizing technology for cervical cancer screening in high-resource settings Expert Review of Obstetrics and Gynecology. 6: 343-353. DOI: 10.1586/eog.11.13  0.467
2011 Franco EL. S12.2 Screening for cervical cancer in the era of HPV vaccination Sexually Transmitted Infections. 87: A14-A15. DOI: 10.1136/sextrans-2011-050102.49  0.42
2010 Ramanakumar AV, Goncalves O, Richardson H, Tellier P, Ferenczy A, Coutlée F, Franco EL. Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. Bmc Infectious Diseases. 10: 326. PMID 21070660 DOI: 10.1186/1471-2334-10-326  0.464
2010 Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JC, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Research. 70: 8569-77. PMID 20978200 DOI: 10.1158/0008-5472.Can-10-0621  0.401
2010 Franco EL. Persistent HPV infection and cervical cancer risk: Is the scientific rationale for changing the screening paradigm enough? Journal of the National Cancer Institute. 102: 1451-1453. PMID 20841606 DOI: 10.1093/jnci/djq357  0.474
2010 Tota J, Mahmud SM, Ferenczy A, Coutĺe F, Franco EL. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era Sexual Health. 7: 376-382. PMID 20719230 DOI: 10.1071/SH10022  0.451
2010 Alvarez J, de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Allaire G, Hadjeres R, Franco EL, Coutlée F. Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men. Aids (London, England). 24: 2355-63. PMID 20706109 DOI: 10.1097/QAD.0b013e32833db9ea  0.353
2010 Siegel EM, Salemi JL, Villa LL, Ferenczy A, Franco EL, Giuliano AR. Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecologic Oncology. 118: 289-94. PMID 20691333 DOI: 10.1016/J.Ygyno.2010.05.022  0.466
2010 Siegel EM, Salemi JL, Craft NE, Villa LL, Ferenczy AS, Franco EL, Giuliano AR. No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women. Cancer Prevention Research (Philadelphia, Pa.). 3: 1007-14. PMID 20606041 DOI: 10.1158/1940-6207.Capr-09-0239  0.447
2010 Cornut G, Gagnon S, Hankins C, Money D, Pourreaux K, Franco EL, Coutlée F. Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35 Journal of Medical Virology. 82: 1168-1178. PMID 20513080 DOI: 10.1002/jmv.21777  0.418
2010 Hamlin-Douglas LK, Coutlée F, Roger M, Hanley J, Franco EL, Brassard P. Determinants of human papillomavirus infection among Inuit women of northern Quebec, Canada. Sexually Transmitted Diseases. 37: 377-81. PMID 20473246 DOI: 10.1097/OLQ.0b013e3181cc4d22  0.415
2010 Ogilvie GS, van Niekerk DJ, Krajden M, Martin RE, Ehlen TG, Ceballos K, Peacock SJ, Smith LW, Kan L, Cook DA, Mei W, Stuart GC, Franco EL, Coldman AJ. A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). Bmc Cancer. 10: 111. PMID 20334685 DOI: 10.1186/1471-2407-10-111  0.446
2010 Rosen NO, Knäuper B, Di Dio P, Morrison E, Tabing R, Feldstain A, Amsel R, Mayrand MH, Franco EL, Rosberger Z. The impact of intolerance of uncertainty on anxiety after receiving an informational intervention about HPV: a randomised controlled study. Psychology & Health. 25: 651-68. PMID 20204959 DOI: 10.1080/08870440902822913  0.444
2010 Ramanakumar AV, Thomann P, Candeias JM, Ferreira S, Villa LL, Franco EL. Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection. Journal of Clinical Microbiology. 48: 791-6. PMID 20053861 DOI: 10.1128/JCM.00844-09  0.447
2010 Burchell AN, Tellier PP, Hanley J, Coutlée F, Franco EL. Human papillomavirus infections among couples in new sexual relationships. Epidemiology (Cambridge, Mass.). 21: 31-7. PMID 19907332 DOI: 10.1097/EDE.0b013e3181c1e70b  0.358
2010 Burchell AN, Tellier PP, Hanley J, Coutlée F, Franco EL. Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner. Sexually Transmitted Diseases. 37: 34-40. PMID 19704391 DOI: 10.1097/OLQ.0b013e3181b35693  0.423
2010 Tomita LY, Longatto Filho A, Costa MC, Avilla Andreoli MA, Villa LL, Franco EL, Cardoso MA. Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women International Journal of Cancer. 126: 703-714. PMID 19642096 DOI: 10.1002/ijc.24793  0.433
2009 Franco EL, Tota J. Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions. American Journal of Epidemiology. 171: 164-8. PMID 20007675 DOI: 10.1093/aje/kwp392  0.47
2009 Franco EL. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening Journal of the National Cancer Institute. 101: 1600-1601. PMID 19903806 DOI: 10.1093/jnci/djp392  0.318
2009 Kulasingam SL, Rajan R, St Pierre Y, Atwood CV, Myers ER, Franco EL. Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. Bmc Medicine. 7: 69. PMID 19900264 DOI: 10.1186/1741-7015-7-69  0.366
2009 Franco EL, Mahmud SM, Tota J, Ferenczy A, Coutlée F. The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change Archives of Medical Research. 40: 478-485. PMID 19853188 DOI: 10.1016/j.arcmed.2009.06.003  0.411
2009 Rosen NO, Knäuper B, Pagé G, Di Dio P, Morrison E, Mayrand MH, Franco EL, Rosberger Z. Brief research report: uncertainty-inducing and reassuring facts about HPV: a descriptive study of French Canadian women. Health Care For Women International. 30: 892-902. PMID 19742363 DOI: 10.1080/07399330903066434  0.443
2009 Franco EL, Coutlée F, Ferenczy A. Integrating human papillomavirus vaccination in cervical cancer control programmes. Public Health Genomics. 12: 352-61. PMID 19684447 DOI: 10.1159/000214925  0.471
2009 Coutlée F, Mayrand MH, Roger M, Franco EL. Detection and typing of human papillomavirus nucleic acids in biological fluids. Public Health Genomics. 12: 308-18. PMID 19684443 DOI: 10.1159/000214921  0.463
2009 Franco EL, Wallace S. How multidisciplinary research advanced the mission of cervical cancer prevention. Public Health Genomics. 12: 264-7. PMID 19684439 DOI: 10.1159/000214917  0.311
2009 Franco EL. Bernard Duval: The architect of Quebec's HPV immunization programme Public Health Genomics. 12: 261-263. PMID 19684438 DOI: 10.1159/000214916  0.373
2009 Franco EL. Is the UK ready to embrace HPV testing? The Lancet Oncology. 10: 643-644. PMID 19573795 DOI: 10.1016/S1470-2045(09)70177-9  0.417
2009 Coutlée F, Trottier H, Gagnon S, Koushik A, Richardson H, Roger M, Ferenczy AS, Franco EL. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 45: 96-9. PMID 19398216 DOI: 10.1016/J.Jcv.2009.03.019  0.446
2009 de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Macleod J, Allaire G, Franco EL, Coutlée F. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. The Journal of Infectious Diseases. 199: 965-73. PMID 19239366 DOI: 10.1086/597207  0.373
2009 Trottier H, Mahmud SM, Lindsay L, Jenkins D, Quint W, Wieting SL, Schuind A, Franco EL. Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women Cancer Epidemiology Biomarkers and Prevention. 18: 854-862. PMID 19223559 DOI: 10.1158/1055-9965.EPI-08-1012  0.441
2009 Hamlin-Douglas LK, Coutlée F, Roger M, Franco EL, Brassard P. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3141-9. PMID 18990756 DOI: 10.1158/1055-9965.EPI-08-0625  0.393
2009 Spence AR, Franco ELF. Screening for Cervical Cancer Using HPV Tests The Cervix: Second Edition. 373-386. DOI: 10.1002/9781444312744.ch26  0.715
2008 Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. International Journal of Cancer. 124: 516-20. PMID 18973271 DOI: 10.1002/ijc.24010  0.481
2008 Muñoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ, Bosch FX. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine. 26: L96-L107. PMID 18945407 DOI: 10.1016/J.Vaccine.2008.05.062  0.36
2008 Franco EL, Tsu V, Herrero R, Lazcano-Ponce E, Hildesheim A, Muñoz N, Murillo R, Sánchez GI, Andrus JK. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine. 26: L88-95. PMID 18945406 DOI: 10.1016/j.vaccine.2008.05.026  0.406
2008 de Araujo Souza PS, Maciag PC, Ribeiro KB, Petzl-Erler ML, Franco EL, Villa LL. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. Bmc Cancer. 8: 246. PMID 18721466 DOI: 10.1186/1471-2407-8-246  0.484
2008 Gohy L, Gorska I, Rouleau D, Ghattas G, Pokomandy Ad, Vézina S, Coté P, Macleod J, Allaire G, Hadjeres R, Kornegay JR, Franco E. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. Journal of Acquired Immune Deficiency Syndromes. 49: 32-39. PMID 18667921 DOI: 10.1097/Qai.0B013E318183A905  0.535
2008 Franco EL, Cuzick J. Cervical cancer screening following prophylactic human papillomavirus vaccination. Vaccine. A16-23. PMID 18642468 DOI: 10.1016/j.vaccine.2007.11.069  0.426
2008 Azizi N, Brazete J, Hankins C, Money D, Fontaine J, Koushik A, Rachlis A, Pourreaux K, Ferenczy A, Franco E, Coutlée F. Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia Journal of General Virology. 89: 1716-1728. PMID 18559943 DOI: 10.1099/Vir.0.83579-0  0.511
2008 Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. The Journal of Infectious Diseases. 197: 1436-47. PMID 18419547 DOI: 10.1086/587698  0.365
2008 Franco EL, Spence AR. Commentary: Smoking and human papillomavirus infection: the pursuit of credibility for an epidemiologic association. International Journal of Epidemiology. 37: 547-8. PMID 18367497 DOI: 10.1093/Ije/Dyn057  0.727
2008 Ades S, Koushik A, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Roger M, Franco EL. Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. International Journal of Cancer. Journal International Du Cancer. 122: 2820-6. PMID 18351579 DOI: 10.1002/Ijc.23459  0.47
2008 Gorska-Flipot I, Sawick J, Gaboury LA, Krajinovic M, Labuda D, Brukner I, Rouleau D, Ghattas G, Franco EL, Coutlée F. Newly-isolated HPV97, related to HPV18 and 45 is frequently detected in HIV-positive men from the Montreal area. International Journal of Cancer. 122: 1195-7. PMID 17960620 DOI: 10.1002/Ijc.23133  0.363
2008 Franco EL, Paavonen J. Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention Therapy. 5: 261-263. DOI: 10.2217/14750708.5.3.261  0.33
2008 Franco EL. Human Papillomavirus and Cervical Cancer: Integrating the New Prevention Strategies Aacr Education Book. 2008: 367-373. DOI: 10.1158/AACR.EDB-08-8115  0.354
2007 Franco EL, de Pokomandy A, Spence AR, Burchell AN, Trottier H, Mayrand MH, Lau S. Vaccination against human papillomavirus. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 177: 1524-5; author reply. PMID 18056600 DOI: 10.1503/cmaj.1070120  0.582
2007 Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. The New England Journal of Medicine. 357: 1579-88. PMID 17942871 DOI: 10.1056/NEJMoa071430  0.383
2007 Zaratti L, Senatore S, Franco E. Screening and vaccination: two synergic tools for the prevention of cervical cancer Igiene E Sanità Pubblica. 63: 449-457. PMID 17912281  0.426
2007 Coutlée F, Rouleau D, Ghattas G, Hankins C, Vézina S, Coté P, Macleod J, De Pokomandy A, Money D, Walmsley S, Voyer H, Brassard P, Franco E. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test Journal of Clinical Microbiology. 45: 3821-3823. PMID 17898159 DOI: 10.1128/Jcm.01145-07  0.531
2007 Franco EL. Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted British Medical Journal. 335: 378-379. PMID 17717367  0.335
2007 Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Matlashewski G, Roger M, Ferenczy AS, Franco EL, Coutlée F. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix. International Journal of Cancer. 121: 2674-81. PMID 17708553 DOI: 10.1002/Ijc.23006  0.42
2007 Ferenczy A, Franco EL. Prophylactic human papillomavirus vaccines: potential for sea change. Expert Review of Vaccines. 6: 511-25. PMID 17669006 DOI: 10.1586/14760584.6.4.511  0.382
2007 Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Preventive Medicine. 45: 93-106. PMID 17651792 DOI: 10.1016/J.Ypmed.2007.06.007  0.645
2007 Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine. 25: 6257-70. PMID 17606315 DOI: 10.1016/J.Vaccine.2007.05.058  0.31
2007 Franco EL, Ferenczy A. Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination. Future Oncology (London, England). 3: 319-27. PMID 17547527 DOI: 10.2217/14796694.3.3.319  0.425
2007 Mahmud SM, Robinson K, Richardson H, Tellier PP, Ferenczy AS, Roger M, Coutlée F, Franco EL. HLA polymorphisms and cervical human papillomavirus infection in a cohort of Montreal university students Journal of Infectious Diseases. 196: 82-90. PMID 17538887 DOI: 10.1086/518612  0.482
2007 Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ. Multiparameter calibration of a natural history model of cervical cancer. American Journal of Epidemiology. 166: 137-50. PMID 17526866 DOI: 10.1093/Aje/Kwm086  0.405
2007 Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, Herrero R, Coutlée F, Franco EL. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncology. 44: 242-50. PMID 17467327 DOI: 10.1016/j.oraloncology.2007.02.005  0.51
2007 Brogly SB, Watts DH, Ylitalo N, Franco EL, Seage GR, Oleske J, Eagle M, Van Dyke R. Reproductive health of adolescent girls perinatally infected with HIV. American Journal of Public Health. 97: 1047-52. PMID 17463385 DOI: 10.2105/AJPH.2005.071910  0.598
2007 Schaffer A, Koushik A, Trottier H, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Pollak MN, Franco EL. Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 716-22. PMID 17416762 DOI: 10.1158/1055-9965.Epi-06-0924  0.434
2007 Al-Qahtani K, Brousseau V, Paczesny D, Domanowski G, Hamid Q, Hier M, Black M, Franco E, Kost K. Koilocytosis in oral squamous cell carcinoma: What does it mean? Journal of Otolaryngology. 36: 26-31. PMID 17376347 DOI: 10.2310/7070.2006.0049  0.461
2007 Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecologic Oncology. 105: 530-5. PMID 17335880 DOI: 10.1016/j.ygyno.2007.01.023  0.345
2007 Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. International Journal of Cancer. 120: 1763-8. PMID 17230525 DOI: 10.1002/ijc.22481  0.486
2007 Kohli M, Ferko N, Martin A, Franco EL, Jenkins D, Gallivan S, Sherlaw-Johnson C, Drummond M. Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. British Journal of Cancer. 96: 143-50. PMID 17146475 DOI: 10.1038/sj.bjc.6603501  0.392
2007 Siegel EM, Craft NE, Duarte-Franco E, Villa LL, Franco EL, Giuliano AR. Associations between serum carotenoids and tocopherols and type-specific HPV persistence: The Ludwig-McGill cohort study International Journal of Cancer. 120: 672-680. PMID 17096322 DOI: 10.1002/Ijc.22346  0.461
2007 Gagnon S, Hankins C, Money D, Pourreaux K, Conners J, Grimshaw R, Haase D, Johnston L, Schlech W, Yuzicappi-Fayant A, Landis S, Smaill F, Austin T, Hammerberg O, Ralph T, ... ... Franco E, et al. Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIV Journal of Acquired Immune Deficiency Syndromes. 44: 61-65. PMID 17075388 DOI: 10.1097/01.Qai.0000247226.45375.01  0.507
2007 Brogly SB, Franco EL, Watts DH, Van Dyke R. Brogly et al. respond [4] American Journal of Public Health. 97: 1930. DOI: 10.2105/AJPH.2007.119594  0.504
2006 Trottier H, Franco EL. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. The American Journal of Managed Care. 12: S462-72. PMID 17203990  0.502
2006 Schlecht NF, Trevisan A, Baggio ML, Galan L, Duarte-Franco E, Greenberg MD, Rohan TE, Ferenczy A, Villa LL, Franco EL. Lack of agreement between cervicography and cytology and the effect of human papillomavirus infection and viral load. Journal of Lower Genital Tract Disease. 10: 229-37. PMID 17012988 DOI: 10.1097/01.lgt.0000225892.03613.2c  0.703
2006 Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, Franco EL, Coutlée F. Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. The Journal of Infectious Diseases. 194: 886-94. PMID 16960775 DOI: 10.1086/507431  0.368
2006 Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 24: S3/52-61. PMID 16950018 DOI: 10.1016/J.Vaccine.2006.05.031  0.391
2006 Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine. 24: S3/251-61. PMID 16950014 DOI: 10.1016/j.vaccine.2006.06.064  0.489
2006 Franco EL, Bosch FX, Cuzick J, Schiller JT, Garnett GP, Meheus A, Wright TC. Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. Vaccine. 24: S3/242-9. PMID 16950013 DOI: 10.1016/j.vaccine.2006.06.038  0.467
2006 Franco EL, Cuzick J, Hildesheim A, de Sanjosé S. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine. S3/171-7. PMID 16844268 DOI: 10.1016/j.vaccine.2006.05.061  0.438
2006 Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1274-80. PMID 16835323 DOI: 10.1158/1055-9965.EPI-06-0129  0.491
2006 Franco EL, Ferenczy A. Is HPV testing with cytological triage a more logical approach in cervical cancer screening? The Lancet. Oncology. 7: 527-9. PMID 16814203 DOI: 10.1016/S1470-2045(06)70735-5  0.439
2006 Coutlée F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vézina S, Coté P, Macleod J, Voyer H, Forest P, Walmsley S, Franco E, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test Journal of Clinical Microbiology. 44: 1998-2006. PMID 16757590 DOI: 10.1128/Jcm.00104-06  0.529
2006 Monsonego J, Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 16: 591-8. PMID 16681731 DOI: 10.1111/J.1525-1438.2006.00361.X  0.533
2006 Alotaibi L, Provost N, Gagnon S, Franco EL, Coutlée F. Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 36: 133-40. PMID 16678481 DOI: 10.1016/j.jcv.2006.02.007  0.314
2006 Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (London, England). 367: 1247-55. PMID 16631880 DOI: 10.1016/S0140-6736(06)68439-0  0.426
2006 Goffin F, Mayrand MH, Gauthier P, Alobaid A, Lussier C, Provencher D, Drouin P, Franco EL, Coutlée F. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. Journal of Medical Virology. 78: 814-9. PMID 16628584 DOI: 10.1002/jmv.20628  0.472
2006 Mayrand MH, Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, Franco EL. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). International Journal of Cancer. 119: 615-23. PMID 16572425 DOI: 10.1002/ijc.21897  0.458
2006 Frazer IH, Cox JT, Mayeaux EJ, Franco EL, Moscicki AB, Palefsky JM, Ferris DG, Ferenczy AS, Villa LL. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. The Pediatric Infectious Disease Journal. 25: S65-81, quiz S82. PMID 16462611 DOI: 10.1097/01.inf.0000196485.86376.46  0.364
2006 Burchell AN, Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, Coutlée F, Franco EL. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. American Journal of Epidemiology. 163: 534-43. PMID 16421235 DOI: 10.1093/aje/kwj077  0.391
2006 Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 24: S1-15. PMID 16406226 DOI: 10.1016/j.vaccine.2005.09.054  0.498
2006 Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Human Papillomavirus Infections With Multiple Types and Risk of Cervical Neoplasia Obstetrical & Gynecological Survey. 61: 706-707. DOI: 10.1097/01.ogx.0000243907.21797.8a  0.392
2006 Bernard L, Lindsay L, Rogoza R, Kohli M, Franco E. PIN21 USE OF EVIDENCE BASED MODELS TO DEMONSTRATE THE LONG-TERM CLINICAL BENEFITS OF HPV VACCINATION Value in Health. 9: A160. DOI: 10.1016/S1098-3015(10)64797-3  0.312
2005 Coutlee F, Rouleau D, Ferenczy A, Franco E. The laboratory diagnosis of genital human papillomavirus infections. Canadian Journal of Infectious Diseases & Medical Microbiology. 16: 83-91. PMID 18159534 DOI: 10.1155/2005/798710  0.569
2005 Koushik A, Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlée F, Franco EL. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detection and Prevention. 29: 307-16. PMID 16122882 DOI: 10.1016/J.Cdp.2005.06.007  0.426
2005 Richardson H, Abrahamowicz M, Tellier PP, Kelsall G, du Berger R, Ferenczy A, Coutlée F, Franco EL. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1149-56. PMID 15894665 DOI: 10.1158/1055-9965.Epi-04-0230  0.477
2005 Franco EL, Harper DM. Vaccination against human papillomavirus infection: A new paradigm in cervical cancer control Vaccine. 23: 2388-2394. PMID 15755633 DOI: 10.1016/j.vaccine.2005.01.016  0.457
2005 Sichero L, Franco EL, Villa LL. Different P105 promoter activities among natural variants of human papillomavirus type 18. The Journal of Infectious Diseases. 191: 739-42. PMID 15688288 DOI: 10.1086/427825  0.406
2005 Spence AR, Franco EL, Ferenczy A. The role of human papillomaviruses in cancer: Evidence to date American Journal of Cancer. 4: 49-64. DOI: 10.2165/00024669-200504010-00004  0.729
2005 Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, Decarvalho NS, Roteli-Martins CM, Teixeira J, Blotter MM, Kom AP, Quint W, et al. Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial Obstetrical & Gynecological Survey. 60: 171-173. DOI: 10.1097/01.Ogx.0000154423.27940.68  0.439
2004 Roy MC, Mayrand MH, Franco E, Arseneau J, Ferenczy A. Electrofulguration for low-grade squamous intraepithelial lesions of the cervix (CIN 1). Journal of Lower Genital Tract Disease. 8: 10-5. PMID 15874830 DOI: 10.1097/00128360-200401000-00004  0.369
2004 Healey SM, Aronson K, Mao Y, Franco EL. Human papillomavirus and cervical dysplasia in Nunavut: prelude to a screening strategy. International Journal of Circumpolar Health. 63: 199-201. PMID 15736652 DOI: 10.3402/ijch.v63i0.17901  0.431
2004 Stuart G, Taylor G, Bancej CM, Beaulac J, Colgan T, Franco EL, Kropp RY, Lotocki R, Mai V, McLachlin CM, Onysko J, Martin RE, Elit L, Guijon F, Mann J, et al. Report of the 2003 pan-Canadian forum on cervical cancer prevention and control. Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'Obstã©Trique Et Gynã©Cologie Du Canada : Jogc. 26: 1004-28. PMID 15560864 DOI: 10.1016/S1701-2163(16)30423-6  0.466
2004 Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (London, England). 364: 1757-65. PMID 15541448 DOI: 10.1016/S0140-6736(04)17398-4  0.425
2004 Duarte-Franco E, Franco EL. Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers. Bmc Women's Health. S14. PMID 15345077 DOI: 10.1186/1472-6874-4-S1-S14  0.369
2004 Duarte-Franco E, Franco EL. Cancer of the Uterine Cervix. Bmc Women's Health. S13. PMID 15345076 DOI: 10.1186/1472-6874-4-S1-S13  0.45
2004 Bruneau J, Brogly SB, Tyndall MW, Lamothe F, Franco EL. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction (Abingdon, England). 99: 727-37. PMID 15139871 DOI: 10.1111/j.1360-0443.2004.00713.x  0.558
2004 Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. Journal of the National Cancer Institute. 96: 604-15. PMID 15100338 DOI: 10.1093/Jnci/Djh104  0.46
2004 Franco EL. Randomized Controlled Trials of HPV Testing and Pap Cytology: Toward Evidence-Based Cervical Cancer Prevention International Journal of Cancer. 110: 1-2. PMID 15054862 DOI: 10.1002/ijc.20074  0.44
2004 Pinto AP, Schlecht NF, Pintos J, Kaiano J, Franco EL, Crum CP, Villa LL. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecologic Oncology. 92: 856-65. PMID 14984953 DOI: 10.1016/j.ygyno.2003.11.052  0.644
2004 Mahmud S, Franco E, Aprikian A. Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. British Journal of Cancer. 90: 93-9. PMID 14710213 DOI: 10.1038/Sj.Bjc.6601416  0.307
2004 Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright TC, Kinney W, Meijer CJ, Linder J, McGoogan E, Meijer C, et al. Cervical cancer control, priorities and new directions. International Journal of Cancer. Journal International Du Cancer. 108: 329-33. PMID 14648697 DOI: 10.1002/Ijc.11530  0.576
2004 Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlée F, Franco EL. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 485-90. PMID 12814991  0.471
2004 Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE, Franco EL, Duarte-Franco EF. Screening every three years, instead of annually, would result in a small increase in risk of cervical cancer Evidence-Based Obstetrics and Gynecology. 6: 204-205. DOI: 10.1016/J.Ebobgyn.2004.09.009  0.328
2003 Li J, Rousseau MC, Franco EL, Ferenczy A. Is colposcopy warranted in women with external anogenital warts? Journal of Lower Genital Tract Disease. 7: 22-8. PMID 17051040 DOI: 10.1097/00128360-200301000-00006  0.6
2003 Franco EL, Duarte-Franco E, Ferenczy A. Prospects for controlling cervical cancer at the turn of the century Salud Publica De Mexico. 45. PMID 14746030  0.444
2003 Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer Journal (Sudbury, Mass.). 9: 348-59. PMID 14690309 DOI: 10.1097/00130404-200309000-00004  0.726
2003 Giuliano AR, Siegel EM, Roe DJ, Ferreira S, Baggio ML, Galan L, Duarte-Franco E, Villa LL, Rohan TE, Marshall JR, Franco EL. Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. The Journal of Infectious Diseases. 188: 1508-16. PMID 14624376 DOI: 10.1086/379197  0.465
2003 Wolf JK, Franco EL, Arbeit JM, Shroyer KR, Wu TC, Runowicz CD, Tortolero-Luna G, Herrero R, Crum CP. Innovations in understanding the biology of cervical cancer. Cancer. 98: 2064-9. PMID 14603543 DOI: 10.1002/cncr.11682  0.48
2003 Rohan TE, Burk RD, Franco EL. Toward a reduction of the global burden of cervical cancer American Journal of Obstetrics and Gynecology. 189. PMID 14586318 DOI: 10.1067/S0002-9378(03)01079-2  0.462
2003 Schlecht NF, Platt RW, Negassa A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions. American Journal of Epidemiology. 158: 878-86. PMID 14585766 DOI: 10.1093/aje/kwg235  0.699
2003 Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 1029-37. PMID 14578139  0.673
2003 Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. Journal of the National Cancer Institute. 95: 1336-43. PMID 12953088  0.69
2003 Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. International Journal of Cancer. Journal International Du Cancer. 106: 896-904. PMID 12918067 DOI: 10.1002/Ijc.11334  0.559
2003 Rousseau MC, Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sexually Transmitted Diseases. 30: 581-7. PMID 12838088 DOI: 10.1097/00007435-200307000-00010  0.697
2003 Franco EL. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests Journal of the National Cancer Institute. Monographs. 89-96. PMID 12807951  0.446
2003 Brogly S, Mercier C, Bruneau J, Palepu A, Franco E. Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale. Substance Use & Misuse. 38: 965-92. PMID 12801151 DOI: 10.1081/Ja-120017619  0.566
2003 Nonnenmacher B, Pintos J, Bozzetti MC, Mielzinska-Lohnas I, Lorincz AT, Ikuta N, Schwartsmann G, Villa LL, Schiller JT, Franco E. Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer International Journal of Std & Aids. 14: 258-265. PMID 12716496 DOI: 10.1258/095646203321264872  0.563
2003 Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous A, Drouin P, Wheeler CM, Dubuc-Lissoir J, Gauthier P, Allaire G, Vauclair R, Dipaolo JA, Gravitt P, Franco E, Coutlée F. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. American Journal of Obstetrics and Gynecology. 188: 129-34. PMID 12548206 DOI: 10.1067/Mob.2003.66  0.339
2003 Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. International Journal of Cancer. 103: 519-24. PMID 12478669 DOI: 10.1002/ijc.10846  0.703
2003 Goldie S, Kohli M, Grima D, Weinstein M, Wright T, Bosch F, Franco E. PIN18 PROJECTED CLINICAL BENEFITS AND COSTEFFECTIVENESS OF AN HPV 16/18 VACCINE Value in Health. 6: 752. DOI: 10.1016/S1098-3015(10)61915-8  0.323
2002 Nishimoto IN, Pintos J, Schlecht NF, Torloni H, Carvalho AL, Kowalski LP, Franco EL. Assessment of control selection bias in a hospital-based case-control study of upper aero-digestive tract cancers. Journal of Cancer Epidemiology and Prevention. 7: 131-41. PMID 12665212  0.549
2002 Villa LL, Bernard HU, Kast M, Hildesheim A, Amestoy G, Franco EL. Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference-HPV2001. Virus Research. 89: 163-73. PMID 12445656 DOI: 10.1016/S0168-1702(02)00185-5  0.373
2002 Tran-Thanh D, Koushik A, Provencher D, Drouin P, Dubuc-Lissoir J, Gauthier P, Allaire G, Kornegay J, Franco E, Coutlée F. Detection of human herpes virus type 6 DNA in precancerous lesions of the uterine cervix. Journal of Medical Virology. 68: 606-10. PMID 12376970 DOI: 10.1002/Jmv.10229  0.54
2002 Maciag PC, Schlecht NF, Souza PS, Rohan TE, Franco EL, Villa LL. Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. The Journal of Infectious Diseases. 186: 164-72. PMID 12134251 DOI: 10.1086/341080  0.683
2002 Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia Lancet Oncology. 3: 11-16. PMID 11905599 DOI: 10.1016/S1470-2045(01)00617-9  0.558
2002 Brogly SB, Bruneau J, Lamothe F, Vincelette J, Franco EL. HIV-positive notification and behavior changes in Montreal injection drug users. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 14: 17-28. PMID 11900107 DOI: 10.1521/aeap.14.1.17.24333  0.552
2002 Carvalho AL, Pintos J, Schlecht NF, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck. Archives of Otolaryngology--Head & Neck Surgery. 128: 313-8. PMID 11886350 DOI: 10.1001/Archotol.128.3.313  0.552
2002 Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples Journal of Clinical Microbiology. 40: 902-907. PMID 11880413 DOI: 10.1128/Jcm.40.3.902-907.2002  0.501
2002 Goldie S, Grima D, Kohli M, Weinstein M, Wright T, Franco E. PIN37 A COMPREHENSIVE NATURAL HISTORY MODEL OF HUMAN PAPILLOMAVIRUS (HPV) INFECTION AND CERVICAL CANCER: POTENTIAL IMPACT OF AN HPV 16/18 VACCINE Value in Health. 5: 576. DOI: 10.1016/S1098-3015(10)61515-X  0.466
2001 Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000 Lancet Oncology. 2: 27-32. PMID 11905615 DOI: 10.1016/S1470-2045(00)00192-3  0.446
2001 Schlecht NF, Franco EL, Rohan TE, Kjaer SK, Schiffman MH, Moscicki AB, Duffy SW. Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: determinants of reporting error at follow-up interviews. Journal of Epidemiology and Biostatistics. 6: 393-407. PMID 11822729 DOI: 10.1080/135952201753337149  0.589
2001 Yoskovitch A, Frenkiel S, Franco E, Coutlée F, Nachtigal D, Rochon L. Analysis of human papillomavirus in schneiderian papillomas as compared to chronic sinusitis and normal nasal mucosa. The Journal of Otolaryngology. 30: 167-72. PMID 11771047 DOI: 10.2310/7070.2001.20037  0.519
2001 Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. Jama. 286: 3106-14. PMID 11754676 DOI: 10.1001/Jama.286.24.3106  0.714
2001 Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. The Journal of Infectious Diseases. 184: 1508-17. PMID 11740725 DOI: 10.1086/324579  0.66
2001 Healey SM, Aronson KJ, Mao Y, Schlecht NF, Mery LS, Ferenczy A, Franco EL. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sexually Transmitted Diseases. 28: 694-700. PMID 11725224  0.712
2001 Kornegay JR, Shepard AP, Hankins C, Franco E, Lapointe N, Richardson H, Coutleé F, Gill J, Romanowski B, Shafran S, Grimshaw R, Haase D, Johnston L, Schlech W, Landis S, et al. Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format Journal of Clinical Microbiology. 39: 3530-3536. PMID 11574568 DOI: 10.1128/Jcm.39.10.3530-3536.2001  0.469
2001 Schlecht NF, Pintos J, Kowalski LP, Franco EL. Effect of type of alcoholic beverage on the risks of upper aerodigestive tract cancers in Brazil. Cancer Causes & Control : Ccc. 12: 579-87. PMID 11552705 DOI: 10.1023/A:1011226520220  0.56
2001 Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: Epidemiology, prevention and the role of human papillomavirus infection Cmaj. 164: 1017-1025. PMID 11314432  0.472
2001 Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. The Journal of General Virology. 81: 2959-2968. PMID 11086127 DOI: 10.1099/0022-1317-81-12-2959  0.496
2001 Rohan TE, Burk RD, Franco EL. Toward a reduction of the global burden of cervical cancer Clinical Journal of Woman's Health. 1: 103-106. DOI: 10.1053/cjwh.2001.21225  0.341
2000 Brogly SB, Bruneau J, Vincelette J, Lamothe F, Franco EL. Risk behaviour change and HIV infection among injection drug users in Montreal. Aids (London, England). 14: 2575-82. PMID 11101070 DOI: 10.1097/00002030-200011100-00021  0.579
2000 Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 9: 1183-91. PMID 11097225  0.691
2000 Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R, Storey A, Matlashewski G. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. International Journal of Cancer. Journal International Du Cancer. 87: 528-33. PMID 10918193 DOI: 10.1002/1097-0215(20000815)87:4<528::AID-IJC11>3.0.CO;2-O  0.452
2000 Franco EL. Statistical issues in human papillomavirus testing and screening Clinics in Laboratory Medicine. 20: 345-367. PMID 10863644  0.426
2000 Rousseau MC, Franco EL, Villa LL, Sobrinho JP, Termini L, Prado JM, Rohan TE. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 9: 469-76. PMID 10815691  0.681
2000 Richardson H, Franco E, Pintos J, Bergeron J, Arella M, Tellier P. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students. Sexually Transmitted Diseases. 27: 79-86. PMID 10676974 DOI: 10.1097/00007435-200002000-00005  0.55
1999 Schlecht NF, Franco EL, Pintos J, Negassa A, Kowalski LP, Oliveira BV, Curado MP. Interaction between tobacco and alcohol consumption and the risk of cancers of the upper aero-digestive tract in Brazil. American Journal of Epidemiology. 150: 1129-37. PMID 10588073  0.57
1999 Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G, Baggio M, Caballero O, Candeias J, Ferreira S, Galan L, Prado J, Rahal P, Ribeiro M, Ruiz A, et al. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil Revista Panamericana De Salud Publica/Pan American Journal of Public Health. 6: 223-233. PMID 10572472 DOI: 10.1590/S1020-49891999000900001  0.737
1999 Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. The Journal of Infectious Diseases. 180: 1415-23. PMID 10515798 DOI: 10.1086/315086  0.631
1999 Schlecht NF, Franco EL, Pintos J, Kowalski LP. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology (Cambridge, Mass.). 10: 412-8. PMID 10401876 DOI: 10.1097/00001648-199907000-00009  0.559
1999 Coutlée F, Gravitt P, Richardson H, Hankins C, Franco E, Lapointe N, Voyer H, Gill J, Romanowski B, Shafran S, Grimshaw R, Haase D, Schlech W, Landis S, Sellors J, et al. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay Journal of Clinical Microbiology. 37: 1852-1857. PMID 10325336 DOI: 10.1128/Jcm.37.6.1852-1857.1999  0.427
1999 Pintos J, Franco EL, Black MJ, Bergeron J, Arella M. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract Cancer. 85: 1903-1909. PMID 10223228 DOI: 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6  0.398
1999 Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. Journal of the National Cancer Institute. 91: 506-11. PMID 10088620 DOI: 10.1093/Jnci/91.6.506  0.394
1998 Velly AM, Franco EL, Schlecht N, Pintos J, Kowalski LP, Oliveira BV, Curado MP. Relationship between dental factors and risk of upper aerodigestive tract cancer. Oral Oncology. 34: 284-91. PMID 9813724 DOI: 10.1016/S1368-8375(98)80009-2  0.601
1998 Allison P, Franco E, Black M, Feine J. The role of professional diagnostic delays in the prognosis of upper aerodigestive tract carcinoma Oral Oncology. 34: 147-153. PMID 9682779 DOI: 10.1016/S1368-8375(97)00088-2  0.349
1998 Allison P, Franco E, Feine J. Predictors of professional diagnostic delays for upper aerodigestive tract carcinoma Oral Oncology. 34: 127-132. PMID 9682776 DOI: 10.1016/S1368-8375(97)00078-X  0.346
1998 Ferenczy A, Gelfand MM, Franco E, Mansour N. Human Papillomavirus Infection in Postmenopausal Women With and Without Hormone Therapy Journal of Lower Genital Tract Disease. 2: 40. DOI: 10.1097/00128360-199801000-00017  0.314
1997 Franco EL. Understanding the epidemiology of genital infection with oncogenic and nononcogenic human papillomaviruses: A promising lead for primary prevention of cervical cancer Cancer Epidemiology Biomarkers and Prevention. 6: 759-761. PMID 9332755  0.366
1997 Coutlée F, Mayrand M, Provencher D, Franco E. The future of HPV testing in clinical laboratories and applied virology research Clinical and Diagnostic Virology. 8: 123-141. PMID 9316734 DOI: 10.1016/S0928-0197(97)00021-4  0.557
1997 Ferenczy A, Gelfand MM, Franco E, Mansour N. Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstetrics & Gynecology. 90: 7-11. PMID 9207803 DOI: 10.1016/S0029-7844(97)00217-2  0.551
1996 Ferenczy A, Robitaille J, Franco E, Arseneau J, Richart RM, Wright TC. Conventional cervical cytologic smears vs. ThinPrep smears : A paired comparison study on cervical cytology Acta Cytologica. 40: 1136-1142. PMID 8960019 DOI: 10.1159/000333971  0.392
1996 Franco ELF. Epidemiology of anogenital warts and cancer Obstetrics and Gynecology Clinics of North America. 23: 597-623. PMID 8869948  0.473
1995 Franco EL. Cancer causes revisited: Human papillomavirus and cervical neoplasia Journal of the National Cancer Institute. 87: 779-780. PMID 7791221 DOI: 10.1093/jnci/87.11.779  0.401
1995 Siemiatycki J, Krewski D, Franco E, Kaiserman M. Associations between cigarette smoking and each of 21 types of cancer: A multi-site case-control study International Journal of Epidemiology. 24: 504-514. PMID 7672889 DOI: 10.1093/Ije/24.3.504  0.345
1995 Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. The Journal of Infectious Diseases. 172: 756-63. PMID 7658069 DOI: 10.1093/infdis/172.3.756  0.452
1995 Franco EL. Recent advances in the molecular epidemiology of cervical cancer Sao Paulo Medical Journal. 113: 28-29. DOI: 10.1590/S1516-31801995000700016  0.32
1994 Siemiatycki J, Dewar R, Krewski D, Désy M, Richardson L, Franco E. Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures? Epidemiology. 5: 57-65. PMID 8117783 DOI: 10.1097/00001648-199401000-00010  0.319
1994 Franco EL, Villa LL, Rahal P, Ruiz A. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. Journal of the National Cancer Institute. 86: 1558-9. PMID 7932815 DOI: 10.1093/Jnci/86.20.1558  0.451
1992 Franco EL. Prognostic Value of Human Papillomavirus in the Survival of Cervical Cancer Patients: An Overview of the Evidence Cancer Epidemiology Biomarkers and Prevention. 1: 499-504. PMID 1338870  0.449
1992 Franco EL. Measurement errors in epidemiological studies of human papillomavirus and cervical cancer Iarc Scientific Publications. 181-197. PMID 1330909  0.492
1991 Franco EL. Viral etiology of cervical cancer: A critique of the evidence Reviews of Infectious Diseases. 13: 1195-1206. PMID 1663652  0.478
1991 Franco EL. The sexually transmitted disease model for cervical cancer: Incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection Epidemiology. 2: 98-106. PMID 1657209  0.347
1989 Villa LL, Franco EL. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. Journal of the National Cancer Institute. 81: 332-40. PMID 2536815 DOI: 10.1093/jnci/81.5.332  0.492
Show low-probability matches.